WallStreetZen

AnalystsChris Cooley
Chris Cooley's Stock Forecasts

Ranking
Top 1%
#26 out of 3515 analysts
Average Return
+124.43%
Win Rate
100%17 out of 17
Risk vs Reward
Poor
Good

Chris Cooley's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Sientra IncSIEN
+605.47%$1.01$7.09
2020-03-23 -
2021-03-23
Strong Buy
Establishment Labs Holdings IncESTA
+442.44%$11.57$62.76
2020-03-23 -
2021-03-23
Strong Buy
Staar Surgical CoSTAA
+289.00%$25.36$98.65
2020-03-23 -
2021-03-23
Strong Buy
Cutera IncCUTR
+178.97%$11.03$30.77
2020-03-23 -
2021-03-23
Strong Buy
Abiomed IncABMD
+125.65%$132.34$298.62
2020-03-23 -
2021-03-23
Strong Buy

Chris Cooley's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Pulse Biosciences IncPLSE
1Strong Buy$28.00-26.79%Initiates Coverage On
5 days ago
GLAUKOS CorpGKOS
1Hold$70.00-27.14%Downgrades
6 days ago
Cooper Companies IncCOO
3Strong Buy$450.00-6.27%Maintains
16 days ago
Align Technology IncALGN
3Strong Buy$700.00-0.60%Upgrades
23 days ago
Vericel CorpVCEL
1Strong Buy$31.00+70.77%Initiates Coverage On
7 months ago
Teleflex IncTFX
1Strong Buy$275.00N/AMaintains
a year ago
STERIS plcSTE
1Strong Buy$145.00N/AMaintains
a year ago
Staar Surgical CoSTAA
1Strong Buy$37.00N/AMaintains
a year ago
Sientra IncSIEN
1Strong Buy$5.00N/AMaintains
a year ago
Establishment Labs Holdings IncESTA
1Strong Buy$23.00N/AMaintains
a year ago
Dexcom IncDXCM
2Strong Buy$240.00N/AMaintains
a year ago
Cutera IncCUTR
1Strong Buy$15.00N/AMaintains
a year ago
Boston Scientific CorpBSX
1Strong Buy$35.00N/AMaintains
a year ago
Alcon IncALC
2Hold$50.00N/AMaintains
a year ago
Abiomed IncABMD
1Strong Buy$155.00N/AMaintains
a year ago
Insulet CorpPODD
1Hold$81.00N/AMaintains
3 years ago
1Strong BuyN/AN/AUpgrades
4 years ago
Invacare CorpIVC
1Strong BuyN/AN/AUpgrades
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.